Mood Tracking for Bipolar Disorder: Methods, Benefits, and Limitations

Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy

A bipolar mood tracker is a structured record of mood, energy, sleep, activity, and other changes across days or weeks. People living with bipolar disorder can use a paper chart, journal, spreadsheet, or smartphone app to bring observations into conversations with their healthcare team. A useful record captures changes relative to a person's usual baseline and connects them to events and functioning over time. It does not assign a diagnosis or reliably predict an episode by itself. National Institute of Mental Health recommends a life chart or mood journal as one self-management aid.

The most important distinction is between helping someone notice and discuss change and proving that tracking itself prevents relapse. The first is a reasonable clinical and practical use; the second remains uncertain. A 2026 systematic review and meta-analysis found no convincing improvement in bipolar mood symptoms attributable to mood-monitoring interventions. At the same time, VA/DoD clinical guidance explicitly incorporates plans for monitoring mood, treatment adherence, and early warning signs into individualized care. Effective tracking begins with that distinction.

For additional clinical context, see Living With Bipolar Disorder: Everyday Routines, Work, and Relationships.

What mood tracking means in bipolar disorder

Bipolar disorder involves clinically significant episodes of depression and elevated or irritable mood with changes in energy, activity, sleep, thinking, and behavior. Mania and hypomania differ in severity and impairment; hypomania is not simply a brief good mood. In bipolar II disorder, recurrent depression may have a major impact even when periods of elevated energy feel productive. Ordinary emotional responses, irritability, and fluctuations on a daily chart should not be relabeled as manic or depressive episodes. Diagnosis requires a longitudinal clinical assessment of symptom clusters, duration, impairment, history, and alternative explanations. NIMH; NICE CG185.

A mood chart is one source of longitudinal information. It can help describe what happened between appointments, support recall of when a change began, and identify patterns that might otherwise be missed. It becomes more clinically meaningful when interpreted alongside a person's history, the observations of trusted people when appropriate, treatment context, and assessment of functioning. Some individuals prefer daily monitoring; others find periodic entries less intrusive. The choice should reflect what information is useful and what level of burden is sustainable.

What should a bipolar mood tracker record?

A practical tracker records enough information to detect change without turning ordinary life into continuous testing. For many adults the core fields are mood, energy or activity, sleep, and a brief account of functioning. Additional fields can be added for medications, major stressors, substance use, early warning signs, and actions agreed with a clinician. Tracking fewer well-defined variables consistently is often more informative than a complicated form completed only during a crisis.

Mood, measured against your own baseline

Choose one scale and define its meaning before using it. For example, a simple five-point scale might range from markedly low, through usual or balanced, to markedly elevated or irritable. Record whether the mood lasted much of the day or was a brief reaction to an event. Add a word such as anxious, sad, irritable, or unusually confident when a number alone loses important context. A number assigned on Monday is an observation, not an objective measure of disease severity.

Energy, activation, and behavior

Record changes in energy, physical activity, speech, pacing of thoughts, social activity, impulsive decisions, and the ability to complete ordinary tasks. These observations can sometimes clarify an apparent mismatch: someone may mark their mood as 'fine' while sleeping little, initiating many projects, talking much faster, and taking unusual financial risks. Elevated mood is not always experienced as happiness; irritability and agitation also matter. NIMH's clinical overview describes the broader changes that characterize manic and depressive episodes.

Sleep and daily rhythms

Write down approximate sleep and wake times, hours slept, and whether the person feels rested. A reduced need for sleep while feeling unusually energized can be clinically different from sleeping poorly and feeling tired the next morning. Shift work, parenting demands, travel, illness, medications, and sleep disorders may also change sleep patterns, so context is essential. For the broader relationship between bipolar episodes and rhythms, read Bipolar Disorder and Sleep. The guidance to maintain consistent routines is part of established bipolar care, although a personal chart cannot determine whether disrupted sleep was a cause, consequence, or correlate of a mood change. NIMH.

Medication and treatment context

A tracker may record prescribed medications taken as directed, missed doses, appointments, changes agreed with the prescriber, and side effects that require discussion. It can help provide a chronology if symptoms change after an adjustment. Logging medication is not a reason to alter treatment independently. Mood stabilizers, antipsychotics, and other treatments have different indications and monitoring needs; the chart is not a substitute for laboratory tests, adverse-effect review, or a clinician's examination. CANMAT/ISBD evidence update; NICE.

Stressors, substances, and life events

Record meaningful changes such as major conflict, bereavement, disrupted routines, unusual work demands, alcohol or drug use, illness, or travel. The presence of two events on the same chart does not establish that one caused the other. A good record helps clinicians ask better questions about timing and alternative explanations rather than generating a simplistic list of personal 'triggers.'

Function, safety, and protective factors

Include brief notes about work or school participation, self-care, relationships, spending, judgment, and the ability to carry out usual responsibilities. It may also be helpful to mark actions that supported stability, such as keeping appointments, sleeping regularly, contacting a support person, or following a previously agreed care plan. When safety becomes an issue, the priority shifts immediately from documentation to assessment and help.

Choosing a method: paper, spreadsheet, app, or passive monitoring

Paper diary or printed mood chart

Paper charting requires little technology, allows flexible notes, and can be kept offline. It is useful for someone who wants a low-stimulation format or prefers to avoid giving sensitive mental-health information to an app company. Its limitations include lost pages, difficulty graphing long periods, and the tendency to fill missed days in retrospect. Older research describes the National Institute of Mental Health Life Chart Method among established paper approaches, though using a familiar format does not guarantee better clinical outcomes. Faurholt-Jepsen et al., 2016.

A spreadsheet or calendar

A spreadsheet can place daily mood, sleep, and energy in adjacent columns, making weekly or monthly patterns easy to review. A calendar may be more intuitive for identifying changes around travel, work schedules, or major life events. Both can be kept relatively simple. The important decisions are where information is stored, who can access it, how securely it is shared, and whether the record is realistically maintainable.

A smartphone mood-tracking app

An app can support reminders, repeated ratings, graphs, and exportable summaries. Some ask for one daily entry, while others prompt several responses a day. The latter approach is often called ecological momentary assessment: repeated in-the-moment observations made during ordinary life. Research uses several methods under the umbrella of digital mood monitoring, and their performance is not interchangeable. A 2026 systematic review found that some active monitoring measures compared reasonably with established clinical measures, but protocols and metrics were highly heterogeneous.

Before adopting an app, check exactly what it collects, whether data remain on the device or go to cloud servers, whether a third party receives data, whether the information can be exported or deleted, and whether reminders can be adjusted. Read the app's current privacy practices rather than assuming that medical-looking branding, graphs, or paid features establish clinical validation. If the tool claims to detect mania, predict relapse, or recommend treatment, look for evidence evaluating that exact function in people with bipolar disorder.

Wearables, sensors, and passive digital signals

Passive monitoring may use information such as activity, movement, sleep estimates, or patterns of phone use without asking the person to make a rating each day. Such measures can be affected by work, disability, travel, social circumstances, device use, and individual behavior. A change in step count is not equivalent to a mood episode. A 2026 review of passive markers included 57 studies and identified substantial limitations in sample sizes, duration, bias, and translation to practice; another 2026 systematic review found sparse evidence supporting the performance of passive assessments. Sensor-driven warnings should therefore be treated as prompts for human review, not automatic clinical conclusions.

How to start mood tracking: a sustainable step-by-step approach

First, decide the purpose with your healthcare professional when possible. A chart used to describe the course of depression may need different fields from one intended to document early signs of elevated activity, clarify effects of disrupted sleep, or prepare for an upcoming appointment. Explicitly define which changes should be discussed with the treatment team and how contact should occur. VA/DoD guideline materials recommend discussing daily self-monitoring tools and when early warning signs should be reported.

Second, establish a personal baseline. Think about what your usual mood, energy, sleep duration, level of activity, and functioning look like when reasonably stable. Baselines differ across individuals and can change over a lifetime. A number without comparison to that baseline is easy to misread.

Third, choose a recording time that fits an ordinary routine. A brief evening check-in may be easier than several interruptions, although people with variable shifts may need another arrangement. Aim to write a short observation at the time it is relevant. If several days are missed, leave them missing or mark retrospective estimates clearly; invented precision makes the chart less useful.

Fourth, start with mood, energy, sleep, and one line of context. Add complexity only when it helps answer a real care-planning question. A paper notebook is sufficient if it is what someone will actually use. There is no evidence that entering numerous daily metrics automatically produces better outcomes.

Fifth, review the record with a clinician at a reasonable interval and compare changes to symptoms, functioning, and the person's experience. Agree on specific responses to meaningful changes rather than setting arbitrary app-generated thresholds. Sixth, periodically reassess whether the process is helpful, tolerable, and proportionate to the information gained.

Example of a simple daily mood record

The following illustration is a sample format, not a validated diagnostic scale. It shows how a few fields can make an observation more informative without using a proprietary tool.

Date: Monday. Mood: close to usual baseline. Energy: usual. Sleep: 7 hours, rested. Function: attended work and kept normal routines. Context: evening walk, routine medication recorded as prescribed.

Date: Tuesday. Mood: unusually elevated and irritable for most of the day. Energy: much higher than usual. Sleep: 4 hours, felt unexpectedly energized. Function: started several unplanned projects and noticed faster speech. Context: no obvious schedule change. Action: followed an existing agreement to contact the treatment team about the combination of changes.

A single illustrative day cannot establish hypomania or mania. What matters clinically is the pattern of symptoms, their duration, severity, effect on functioning, previous episode history, and medical or substance-related explanations. A prospective chart makes the timeline easier to describe; a qualified assessment determines its meaning. NICE; NIMH.

How mood tracking can help

Making clinical conversations more precise

Appointments often ask people to summarize weeks of varied experience in a few minutes. A record can help a person identify when sleep changed, whether low mood persisted, and when daily activities became harder. It may also clarify whether a treatment change preceded a new symptom. This is a practical communication benefit rather than proof that a tracker produces symptom remission.

Recognizing personal early warning patterns

Some people notice recurring signs before a more severe episode, such as reduced need for sleep, sustained changes in energy, increased impulsivity, social withdrawal, or worsening functioning. Recording these patterns may help a person and clinician design an individualized response. The existence of warning signs varies, and the same sign can have other causes. Readers can explore Early Warning Signs of Mania and Bipolar Relapse for clinical distinctions. VA/DoD guidance supports recognizing and reporting early warning signs within care planning.

Supporting an agreed relapse prevention plan

The strongest use of tracking is often relational: a person and clinician agree on the situations in which a change should lead to a call, earlier review, increased support, or use of a prearranged emergency plan. A graph alone cannot implement an appropriate response. A written Bipolar Relapse Prevention Plan can specify warning signs, contacts, safe actions, and responsibilities. Clinical recommendations favor collaborative, individualized care and continuity of treatment. NICE; VA/DoD.

Building a longer-term picture of symptoms

Mood symptoms can fluctuate between acute episodes, and retrospective recall is imperfect. A series of dated observations can help describe changes over months. It may be especially useful when the central question concerns how frequently certain symptoms recur or whether important patterns were present before a treatment decision. However, the pattern should be reviewed for missing data, changes in recording habits, and life-context differences.

What research actually says about mood-tracking benefits

Clinical recommendations and a product's popularity answer different questions from randomized evidence of benefit. The NIMH includes mood journals and life charts among practical self-management ideas; VA/DoD materials recommend planning daily mood monitoring and reporting recurrence signs. These are guidance for comprehensive care, not claims that entering a daily rating alone prevents hospitalization.

The clearest contemporary synthesis is the 2026 meta-analysis by Astill Wright and colleagues, which pooled eight randomized trials including 1,230 participants across depression and bipolar disorder. Among bipolar participants, the pooled results did not establish a clinically convincing reduction in either manic or bipolar-depressive symptoms from mood-monitoring interventions, and evidence for reduced relapse or readmission was absent. The protocols differed, and the findings should not be simplified into a claim that all tracking approaches are useless; they establish that therapeutic effects have not been demonstrated reliably.

Earlier controlled studies also cautioned against optimistic assumptions. The MONARCA I randomized trial enrolled 78 adults and found no significant overall improvement in depressive or manic outcomes from smartphone self-monitoring with a clinical feedback loop over six months. The MONARCA II trial evaluated a different smartphone-based system in 129 participants; its results further underline why the precise intervention, follow-up, and outcome must be examined rather than extrapolating from the existence of an app.

Validity is another distinct question: can a person's app ratings agree with established clinical scales? A 2016 systematic review found stronger convergence for depressive than manic symptom ratings. A 2026 performance review assessed 42 studies with 7,813 participants but documented major heterogeneity across protocols and metrics, limiting comparative conclusions. A tracker may describe subjective experience well yet still miss emerging mania, especially if insight into behavioral changes diminishes.

Taken together, the evidence supports offering tracking as a flexible, optional tool for observation and communication within broader evidence-based care. It does not support presenting self-monitoring alone as a proven treatment, a diagnostic test, or a replacement for medication and psychotherapy when clinically indicated. CANMAT/ISBD; NICE.

Limitations and potential harms

Mood scores are subjective and context-dependent

The same numerical rating may represent quite different experiences across people, weeks, and devices. A one-point change cannot be translated directly into a diagnostic change. Emotions respond to events; some symptoms fluctuate within a day. Even accurate ratings can obscure the difference between a brief emotional reaction and a sustained clinical episode. Whenever possible, pair ratings with concrete changes in sleep, behavior, duration, and function.

Mania and hypomania can be underreported

A person entering an elevated mood state may feel unusually confident or may not identify their behavior as concerning. Self-report alone may therefore underestimate changes that other people notice. The earlier electronic self-monitoring review found weaker validation for mania than depression. An agreed plan can include observations from a trusted supporter with the person's knowledge and consent, while preserving privacy and avoiding intrusive surveillance.

Missing entries, retrospective editing, and false alarms

People are less likely to record consistently when busy, unwell, traveling, or overwhelmed. Missingness may be meaningful, but it can also be ordinary. Multiple alerts can create alarm without establishing risk. Automatic thresholds are rarely transferable between individuals; a change in sleep may reflect deadlines or illness rather than hypomania. Review how an app treats absent data, recalculates scores, or generates warnings.

Rumination, anxiety, and excessive checking

Repeated requests to rate distress can become tiring or increase preoccupation for some people. A 2025 systematic review of adverse events found that reported negative effects were uncommon in available studies, but adverse-event reporting was sparse and inconsistent; the reviewers could not establish that monitoring caused the events. If tracking increases anxiety, shame, compulsive checking, or distress, reducing frequency, simplifying the fields, or discontinuing the tool with the clinician's input may be appropriate. Monitoring should serve the person's goals rather than become a daily performance test.

Privacy, consent, and unequal access

Mood records can reveal diagnoses, medication use, sleep habits, location-linked routines, relationships, and periods of vulnerability. Before sharing information, identify who will see the record, whether it is retained in the cloud, and whether it can be deleted or exported. A family member or employer should not gain automatic access because an app makes sharing convenient. Costs, disability accessibility, literacy, battery life, and inconsistent internet access also influence whether a tool is suitable.

Why algorithms and AI predictions require restraint

Marketing claims may imply that passive signals, wearables, or machine learning can detect a mood episode before it occurs. The 2026 passive-marker systematic review documents promising research but considerable gaps in generalizability, external validation, risk of bias, and readiness for clinical use. Prediction performance established in a selected research sample may not transfer to a different population or device. A proprietary risk score should never override an urgent symptom, a clear safety concern, or clinical judgment.

When to share your chart with a clinician

A chart is most useful when brought with a specific question: 'Do these changes look like my early warning signs?', 'Is the sleep pattern clinically important?', 'Which medication side effects should we evaluate?', or 'What should I do if this combination of symptoms returns?' Summarize the time range, show the days that differ from baseline, and mark gaps honestly. Bring the raw entries when a summary might hide nuance.

Ask for an agreed contact threshold expressed in clinically meaningful terms, such as sustained reduced need for sleep accompanied by activation and behavioral change, or worsening depression with impaired functioning. The exact response depends on personal history and risk. If urgent symptoms are present, do not wait to accumulate enough chart data before seeking help.

What a tracker cannot diagnose

Neither an app score nor a weekly graph can determine whether someone has bipolar I disorder, bipolar II disorder, cyclothymic disorder, or another condition. Mania, hypomania, and major depressive episodes involve defined symptom patterns and clinical context, not merely a high or low number. Diagnosis requires an assessment of episode duration, severity, impairment, previous episodes, medications or substances, medical illness, and differential diagnoses. A structured screening questionnaire is also a screening instrument, not a stand-alone diagnosis; see Bipolar Disorder Screening Tests: MDQ, HCL-32, and Their Limitations. NICE; NIMH.

A clinician may need to distinguish bipolar depression from major depressive disorder, activation from anxiety or ADHD, mood changes associated with drugs or medicines, and altered sleep associated with circadian or sleep disorders. The tracker can provide a timeline for that investigation; it cannot perform the investigation itself. This article focuses on self-observation and care planning rather than reproducing the entire diagnostic framework.

Special circumstances and shared monitoring

During active mania, psychosis, severe depression, or periods of markedly impaired judgment, expecting someone to keep an accurate daily chart may be unrealistic or unsafe. Care decisions should depend on timely professional assessment and previously agreed supports. With consent, relatives or trusted supporters can help describe changes and follow a plan, but their observations are complementary information rather than a substitute for the person's participation and rights. For partner communication and boundaries around sharing mood records, see Bipolar Disorder and Romantic Relationships.

The evidence cited here comes primarily from adult studies. Mood-tracking arrangements for adolescents, pregnant or postpartum people, and older adults require population-specific attention to developmental context, safety, other conditions, medication risks, and available supports. Claims from a general adult smartphone trial should not be assumed valid for those groups. A young person's record should avoid invasive surveillance and be guided by appropriately qualified clinicians.

Urgent warning signs: act on safety, not on the chart

Seek urgent professional assessment if there is rapidly escalating activation with little sleep and impaired judgment, psychotic symptoms, behavior creating immediate danger, severe inability to care for oneself, or suicidal thoughts with intent or a plan. If someone is in immediate danger, use local emergency services or the nearest emergency department. In the United States, call or text 988 for the Suicide & Crisis Lifeline; call 911 for a life-threatening emergency. An app cannot provide emergency monitoring unless that capability is explicitly established and clinically supported. NIMH; VA/DoD clinical guideline.

Practical checklist for choosing a bipolar mood tracker

Choose a method that a person can tolerate and understand, that permits consistent recording of baseline-relative mood, energy, sleep and functional changes, that makes missed entries visible, and that lets them share a concise summary voluntarily with a clinician. Prefer transparent privacy policies and the ability to export or delete information. Treat relapse alerts and algorithmic risk predictions as features requiring separate validation. Decide in advance how the person will obtain help if concerning changes occur.

Review usefulness after a trial period. A sensible question is whether the record clarified an important clinical issue or improved communication without creating undue burden. If the answer is no, a simpler method or a different self-management strategy may fit better. The clinically important element is the continuity of appropriate care, not loyalty to one app.

Frequently asked questions

What is the best bipolar mood tracker?

There is no single tracker established as the best choice for all people with bipolar disorder. A paper life chart, a short daily journal, a spreadsheet, or an app may be appropriate depending on comfort, privacy, accessibility, and the purpose of monitoring. Clinical usefulness comes from relevant entries and a plan for discussing them, not app popularity or graphic design. 2026 monitoring evidence review.

How often should I track my mood?

Many people find a brief daily entry workable because it creates a comparable timeline, but frequency should fit individual needs and capacity. More frequent check-ins can add burden, and evidence does not establish that more measurements automatically improve bipolar outcomes. Agree on a sustainable approach with your treatment team, especially if monitoring is linked to a clinical action plan.

Can a mood tracking app tell me if I am manic?

No app-generated score alone can establish mania. Clinical assessment considers the pattern and duration of symptoms, functional consequences, medical and substance-related explanations, and other sources of information. Self-reported manic symptoms may be particularly difficult to measure accurately during an episode. Faurholt-Jepsen et al., 2016; NIMH.

Is mood tracking a treatment for bipolar disorder?

Mood tracking is primarily an observation and communication practice that may be included in broader care. Randomized evidence has not established that tracking by itself reliably reduces bipolar depression, mania, relapse, or hospitalization. Evidence-based treatment may include phase-specific medications, psychotherapy, psychoeducation, long-term monitoring, and individualized support. Astill Wright et al., 2026; CANMAT/ISBD.

Should I record medication side effects and missed doses?

Yes, when appropriate to the agreed care plan: dated notes about side effects and adherence can help the prescriber understand changes over time. They cannot replace medical monitoring, laboratory tests, or safety assessments. Discuss side effects promptly as advised by the prescribing clinician, and do not stop or change prescribed bipolar medication based only on the chart. NICE.

Can tracking too much make symptoms worse?

Some people report stress, fatigue, or excessive focus on symptoms while monitoring. The 2025 adverse-events review found limitations in how harms were reported and could not establish causality for the reported events. If monitoring becomes burdensome, simplify it or discuss an alternative approach with a clinician. Persistent deterioration or urgent safety concerns always warrant assessment independent of tracking frequency.

What if my mood is normal but my sleep and energy change?

Record the mismatch and any other changes in behavior or functioning. A person can experience clinically meaningful activation without labeling their mood 'high,' and sleep loss may have several causes. Follow an agreed early-warning plan or ask the care team for advice rather than waiting for a numerical mood score to cross a threshold. NIMH; VA/DoD.

Can my family or therapist access my mood chart?

They can see it if you choose to share it or if a separate lawful arrangement applies. Ask who receives the information and how it will be stored. Sharing can support collaborative monitoring, but permissions should be deliberate and proportionate, especially during periods of vulnerability. A tracking app's sharing feature is a privacy decision, not clinical consent by default.

Related Articles

Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment — diagnostic and treatment overview.

Living With Bipolar Disorder: Everyday Routines, Work, and Relationships — practical parent article for ongoing care.

Bipolar Disorder and Sleep: Mood Episodes, Circadian Rhythms, and Prevention — evaluating sleep changes.

Early Warning Signs of Mania and Bipolar Relapse — identifying clinically relevant changes.

Bipolar Relapse Prevention Plan: Warning Signs, Supports, and Crisis Preparation — turning observations into agreed actions.

Bipolar Disorder Screening Tests: MDQ, HCL-32, and Their Limitations — why self-report is different from diagnosis.

Bipolar Disorder and Romantic Relationships: Communication and Boundaries — communication and consent when sharing mood records with a partner.

References

Astill Wright, L., Monk-Cunliffe, J., Guo, B., & Morriss, R. (2025). Adverse events of mood monitoring and ambulatory assessment in depression and bipolar disorder: Systematic review and meta-analysis. JMIR Mental Health, 12, e79500. https://doi.org/10.2196/79500

Astill Wright, L., Bakstein, E., Saunders, K., Guo, B., & Morriss, R. (2026). Performance of active and passive ambulatory assessment measures and mood monitoring in bipolar disorder: A systematic review. International Journal of Bipolar Disorders, 14, 4. https://doi.org/10.1186/s40345-025-00407-5

Astill Wright, L., Shajan, G., Purewal, D., et al. (2026). Mood monitoring, mood tracking, and ambulatory assessment interventions in depression and bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. JMIR Mental Health, 13, e84020. https://doi.org/10.2196/84020

Faurholt-Jepsen, M., Frost, M., Ritz, C., et al. (2015). Daily electronic self-monitoring in bipolar disorder using smartphones—the MONARCA I trial: A randomized, placebo-controlled, single-blind, parallel group trial. Psychological Medicine, 45, 2691–2704. https://doi.org/10.1017/S0033291715000410

Faurholt-Jepsen, M., Munkholm, K., Frost, M., Bardram, J. E., & Kessing, L. V. (2016). Electronic self-monitoring of mood using IT platforms in adult patients with bipolar disorder: A systematic review of the validity and evidence. BMC Psychiatry, 16, 7. https://doi.org/10.1186/s12888-016-0713-0

Faurholt-Jepsen, M., et al. (2019). The effect of smartphone-based monitoring on illness activity in bipolar disorder: The MONARCA II randomized controlled single-blinded trial. Psychological Medicine. https://doi.org/10.1017/S0033291719000710

Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009

Kutcher, T. P., Chakraborty, I., Kostick-Quenet, K., et al. (2026). Digital markers for passive remote monitoring of bipolar disorder: Systematic review. JMIR Mental Health, 13, e94819. https://doi.org/10.2196/94819

National Institute for Health and Care Excellence. (2014; updated). Bipolar disorder: Assessment and management (CG185), Recommendations. NICE CG185

National Institute of Mental Health. (n.d.). Bipolar disorder. NIMH clinical overview

U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. Guideline and resources